235 related articles for article (PubMed ID: 34043194)
1. Differentiation of Midbrain Dopaminergic Neurons from Human iPS Cells.
Ishikawa KI; Nonaka R; Akamatsu W
Methods Mol Biol; 2021; 2322():73-80. PubMed ID: 34043194
[TBL] [Abstract][Full Text] [Related]
2. Physiological characterisation of human iPS-derived dopaminergic neurons.
Hartfield EM; Yamasaki-Mann M; Ribeiro Fernandes HJ; Vowles J; James WS; Cowley SA; Wade-Martins R
PLoS One; 2014; 9(2):e87388. PubMed ID: 24586273
[TBL] [Abstract][Full Text] [Related]
3. Development and Differentiation of Midbrain Dopaminergic Neuron: From Bench to Bedside.
Wang M; Ling KH; Tan JJ; Lu CB
Cells; 2020 Jun; 9(6):. PubMed ID: 32570916
[TBL] [Abstract][Full Text] [Related]
4. Molecular manipulation targeting regulation of dopaminergic differentiation and proliferation of neural stem cells or pluripotent stem cells.
Ding YX; Wei LC; Wang YZ; Cao R; Wang X; Chen LW
CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):517-28. PubMed ID: 21495963
[TBL] [Abstract][Full Text] [Related]
5. Current State-of-the-Art and Unresolved Problems in Using Human Induced Pluripotent Stem Cell-Derived Dopamine Neurons for Parkinson's Disease Drug Development.
Antonov SA; Novosadova EV
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33806103
[TBL] [Abstract][Full Text] [Related]
6. BMP/SMAD Pathway Promotes Neurogenesis of Midbrain Dopaminergic Neurons
Jovanovic VM; Salti A; Tilleman H; Zega K; Jukic MM; Zou H; Friedel RH; Prakash N; Blaess S; Edenhofer F; Brodski C
J Neurosci; 2018 Feb; 38(7):1662-1676. PubMed ID: 29321139
[TBL] [Abstract][Full Text] [Related]
7. Human iPSC-derived midbrain organoids functionally integrate into striatum circuits and restore motor function in a mouse model of Parkinson's disease.
Zheng X; Han D; Liu W; Wang X; Pan N; Wang Y; Chen Z
Theranostics; 2023; 13(8):2673-2692. PubMed ID: 37215566
[No Abstract] [Full Text] [Related]
8. Dickkopf 3 Promotes the Differentiation of a Rostrolateral Midbrain Dopaminergic Neuronal Subset In Vivo and from Pluripotent Stem Cells In Vitro in the Mouse.
Fukusumi Y; Meier F; Götz S; Matheus F; Irmler M; Beckervordersandforth R; Faus-Kessler T; Minina E; Rauser B; Zhang J; Arenas E; Andersson E; Niehrs C; Beckers J; Simeone A; Wurst W; Prakash N
J Neurosci; 2015 Sep; 35(39):13385-401. PubMed ID: 26424886
[TBL] [Abstract][Full Text] [Related]
9. Differentiation and Characterization of Dopaminergic Neurons From Baboon Induced Pluripotent Stem Cells.
Grow DA; Simmons DV; Gomez JA; Wanat MJ; McCarrey JR; Paladini CA; Navara CS
Stem Cells Transl Med; 2016 Sep; 5(9):1133-44. PubMed ID: 27343168
[TBL] [Abstract][Full Text] [Related]
10. Methods to Induce Small-Scale Differentiation of iPS Cells into Dopaminergic Neurons and to Detect Disease Phenotypes.
Yamaguchi A; Ishikawa KI; Akamatsu W
Methods Mol Biol; 2022; 2549():271-279. PubMed ID: 33755905
[TBL] [Abstract][Full Text] [Related]
11. Synthetic mRNAs Drive Highly Efficient iPS Cell Differentiation to Dopaminergic Neurons.
Xue Y; Zhan X; Sun S; Karuppagounder SS; Xia S; Dawson VL; Dawson TM; Laterra J; Zhang J; Ying M
Stem Cells Transl Med; 2019 Feb; 8(2):112-123. PubMed ID: 30387318
[TBL] [Abstract][Full Text] [Related]
12. Monitoring PINK1-Parkin Signaling Using Dopaminergic Neurons from iPS Cells.
Shiba-Fukushima K; Imai Y
Methods Mol Biol; 2021; 2322():81-92. PubMed ID: 34043195
[TBL] [Abstract][Full Text] [Related]
13. Midbrain Dopaminergic Neurons Differentiated from Human-Induced Pluripotent Stem Cells.
Tofoli FA; Semeano ATS; Oliveira-Giacomelli Á; Gonçalves MCB; Ferrari MFR; Veiga Pereira L; Ulrich H
Methods Mol Biol; 2019; 1919():97-118. PubMed ID: 30656624
[TBL] [Abstract][Full Text] [Related]
14. Preparation and Co-Culture of iPSC-Derived Dopaminergic Neurons and Astrocytes.
de Rus Jacquet A
Curr Protoc Cell Biol; 2019 Dec; 85(1):e98. PubMed ID: 31763766
[TBL] [Abstract][Full Text] [Related]
15. Induced dopaminergic neurons: A new promise for Parkinson's disease.
Xu Z; Chu X; Jiang H; Schilling H; Chen S; Feng J
Redox Biol; 2017 Apr; 11():606-612. PubMed ID: 28110217
[TBL] [Abstract][Full Text] [Related]
16. Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model.
Kikuchi T; Morizane A; Doi D; Magotani H; Onoe H; Hayashi T; Mizuma H; Takara S; Takahashi R; Inoue H; Morita S; Yamamoto M; Okita K; Nakagawa M; Parmar M; Takahashi J
Nature; 2017 Aug; 548(7669):592-596. PubMed ID: 28858313
[TBL] [Abstract][Full Text] [Related]
17. Characterization and criteria of embryonic stem and induced pluripotent stem cells for a dopamine replacement therapy.
Cooper O; Parmar M; Isacson O
Prog Brain Res; 2012; 200():265-76. PubMed ID: 23195423
[TBL] [Abstract][Full Text] [Related]
18. Understanding Parkinson's Disease through the Use of Cell Reprogramming.
Playne R; Connor B
Stem Cell Rev Rep; 2017 Apr; 13(2):151-169. PubMed ID: 28083784
[TBL] [Abstract][Full Text] [Related]
19. From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson's Disease Modeling and Regenerative Therapy.
Yeap YJ; Teddy TJW; Lee MJ; Goh M; Lim KL
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768843
[TBL] [Abstract][Full Text] [Related]
20. Derivation of dopaminergic neurons from pluripotent stem cells.
Studer L
Prog Brain Res; 2012; 200():243-63. PubMed ID: 23195422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
